Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Non Operating Income (2022 - 2025)

Envoy Medical's Non Operating Income history spans 4 years, with the latest figure at -$1.4 million for Q3 2025.

  • For Q3 2025, Non Operating Income fell 9386.67% year-over-year to -$1.4 million; the TTM value through Sep 2025 reached $882000.0, up 349.86%, while the annual FY2024 figure was $697000.0, 1190.74% up from the prior year.
  • Non Operating Income for Q3 2025 was -$1.4 million at Envoy Medical, down from -$1000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $4.9 million in Q3 2023 and bottomed at -$9.5 million in Q1 2023.
  • The 4-year median for Non Operating Income is $62000.0 (2024), against an average of -$1.0 million.
  • The largest annual shift saw Non Operating Income soared 1817.7% in 2024 before it plummeted 9386.67% in 2025.
  • A 4-year view of Non Operating Income shows it stood at $457000.0 in 2022, then tumbled by 75.27% to $113000.0 in 2023, then skyrocketed by 1817.7% to $2.2 million in 2024, then plummeted by 164.28% to -$1.4 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Non Operating Income are -$1.4 million (Q3 2025), -$1000.0 (Q2 2025), and $109000.0 (Q1 2025).